Skip to main content
Log in

Cost of Infectious Diseases

  • Published:
Infection Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

References

  • Dietrich ES, Demmler M, Schulgen G, Fekec K, Mast O, Pelz K, Daschner FD: Nosocomial pneumonia: a cost-of-illness analysis. Infection 2002; 30: 61–67 ai}Gastmeier P, Sohr D, Geffers C, Nassauer A, Daschner F, Ruden H: Are nosocomial infection rates in intensive care units useful benchmark parameters? Infection 2000; 28: 346–350.

    Article  CAS  PubMed  Google Scholar 

  • Ruef C: Prevalence of nosocomial infections—who knows the true rates? Infection 1997; 25: 203–205.

    Article  CAS  PubMed  Google Scholar 

  • Fox BC, Imrey PB, Voights MB, Norwood S: Infectious disease consultation and microbiologic surveillance for intensive care unit trauma patients: a pilot study. Clin Infect Dis 2001; 33: 1981–1989.

    Article  CAS  PubMed  Google Scholar 

  • Yinnon AM: Whither infectious diseases consultations? Analysis of 14,005 consultations from a 5-year period. Clin Infect Dis 2001; 33: 1661–1667.

    Article  CAS  PubMed  Google Scholar 

  • Halm EA, Switzer GE, Mittman BS, Walsh MB, Chang CC, Fine MJ: What factors influence physicians' decisions to switch from intravenous to oral antibiotics for community-acquired pneumonia? J Gen Intern Med 2001; 16: 599–605

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  • Pfaller MA: Molecular approaches to diagnosing and managing infectious diseases: practicality and costs. Emerg Infect Dis 2001; 7: 312–318.

    Article  CAS  PubMed  Google Scholar 

  • Garattini L, Tediosi F, Di Cintio E, Yin D, Parazzini F: Resource utilization and hospital cost of HIV/AIDS care in Italy in the era of highly active antiretroviral therapy. AIDS Care 2001; 13:733–741.

    Article  CAS  PubMed  Google Scholar 

  • Keiser P, Nassar N, Kvanli MB, Turner D, Smith JW, Skiest D: Longterm impact of highly active antiretroviral therapy on HIV-related health care costs. J Acquir Immune Defic Syndr 2001; 27: 14–19.

    Article  CAS  PubMed  Google Scholar 

  • Klepser DG: Pitfalls associated with commonly used methods for pharmacoeconomic analyses. Pharmacotherapy 2002; 22: 35S–38S.

    Article  PubMed  Google Scholar 

  • Pollack HA: Cost-effectiveness of harm reduction in preventing hepatitis C among injection drug users. Med Decis Making 2001; 21: 357–367.

    Article  CAS  PubMed  Google Scholar 

  • Accorsi S, Fabiani M, Lukwiya M, Onek PA, Mattei PD, Declich S: The increasing burden of infectious diseases on hospital services at St Mary's Hospital Lacor, Gulu, Uganda. Am J Trop Med Hyg 2001; 64: 154–158.

    CAS  PubMed  Google Scholar 

Download references

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

Ruef, C. Cost of Infectious Diseases. Infection 30, 59–60 (2002). https://doi.org/10.1007/s15010-002-7202-8

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s15010-002-7202-8

Keywords

Navigation